Protein‐Bound Acrolein
暂无分享,去创建一个
[1] E. Niki,et al. Acrolein Is a Product of Lipid Peroxidation Reaction , 1998, The Journal of Biological Chemistry.
[2] M. Tabaton,et al. Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress , 1998, Journal of neurochemistry.
[3] E. Niki,et al. Protein-bound acrolein: potential markers for oxidative stress. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Smith,et al. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. , 1998, The American journal of pathology.
[5] J. Kehrer,et al. Relationships between cell density, glutathione and proliferation of A549 human lung adenocarcinoma cells treated with acrolein. , 1997, Toxicology.
[6] G. Perry,et al. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[7] E. Stadtman,et al. Protein Oxidation in Aging, Disease, and Oxidative Stress* , 1997, The Journal of Biological Chemistry.
[8] Mark A. Smith,et al. 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.
[9] M. Beal,et al. Oxidative damage in Alzheimer's , 1996, Nature.
[10] G. Siest,et al. Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain , 1996, Neuroscience Letters.
[11] D. Butterfield,et al. Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.
[12] E. Stopa,et al. Expression of heme oxygenase‐1 in the senescent and alzheimer‐diseased brain , 1995, Annals of neurology.
[13] D. Price,et al. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. , 1995, The American journal of pathology.
[14] Patrizia Mecocci,et al. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease , 1994, Annals of neurology.
[15] J. Heinecke,et al. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. , 1994, The Journal of biological chemistry.
[16] C. W. Scott,et al. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[17] G. Perry,et al. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. , 1994, The American journal of pathology.
[18] A. Daugherty,et al. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. , 1994, The Journal of clinical investigation.
[19] C. Behl,et al. Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.
[20] M. Mattson,et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[21] E. Stadtman,et al. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[22] N. Robakis,et al. Immunohistochemical evidence of antioxidant stress in Alzheimer's disease , 1992 .
[23] W. Markesbery,et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[24] P. Davies,et al. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[25] M. Nagano,et al. Modifications of neurofilament proteins by possible metabolites of allyl chloride in vitro. , 1995, Drug and chemical toxicology.
[26] H. Esterbauer,et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.
[27] G. Ansari,et al. In vitro covalent modification of serum albumin by acrolein , 1991 .
[28] W. D. Ehmann,et al. Brain trace elements in Alzheimer's disease. , 1986, Neurotoxicology.